{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T10:28:24Z","timestamp":1791109704460,"version":"4.1.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2011,1,11]],"date-time":"2011-01-11T00:00:00Z","timestamp":1294704000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2011,1,11]],"date-time":"2011-01-11T00:00:00Z","timestamp":1294704000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pharmacogenomics J"],"published-print":{"date-parts":[[2012,4]]},"DOI":"10.1038\/tpj.2010.84","type":"journal-article","created":{"date-parts":[[2011,1,11]],"date-time":"2011-01-11T11:06:51Z","timestamp":1294744011000},"page":"96-104","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Genome-wide association study of serious blistering skin rash caused by drugs"],"prefix":"10.1038","volume":"12","author":[{"given":"Y","family":"Shen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Nicoletti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Floratos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Pirmohamed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Molokhia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Geppetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Benemei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B","family":"Giomi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Schena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Vultaggio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Stern","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M J","family":"Daly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"John","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M R","family":"Nelson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I","family":"Pe'er","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"the International Serious Adverse Events Consortium (SAEC)","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,1,11]]},"reference":[{"key":"BFtpj201084_CR1","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1001\/archderm.1990.01670250043005","volume":"126","author":"JC Roujeau","year":"1990","unstructured":"Roujeau JC, Guillaume JC, Fabre JP, Penso D, Fl\u00e9chet ML, Girre JP . Toxic epidermal necrolysis (Lyell syndrome). Incidence and drug etiology in France, 1981\u20131985. Arch Dermatol 1990; 126: 37\u201342.","journal-title":"Arch Dermatol"},{"key":"BFtpj201084_CR2","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1056\/NEJM199411103311906","volume":"331","author":"JC Roujeau","year":"1994","unstructured":"Roujeau JC, Stern RS . Severe adverse cutaneous reactions to drugs. N Engl J Med 1994; 331: 1272\u20131285.","journal-title":"N Engl J Med"},{"key":"BFtpj201084_CR3","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1001\/archderm.1993.01680220104023","volume":"129","author":"S Bastuji-Garin","year":"1993","unstructured":"Bastuji-Garin S, Rzany B, Stern RS, Shear NH, Naldi L, Roujeau J-C . Clinical classification of cases of toxic epidermal necrolysis, Stevens-Johnson syndrome, and erythema multiforme. Arch Dermatol 1993; 129: 92\u201396.","journal-title":"Arch Dermatol"},{"key":"BFtpj201084_CR4","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1111\/j.1445-5994.2005.00790.x","volume":"35","author":"MS Lin","year":"2005","unstructured":"Lin MS, Dai YS, Pwu RF, Chen YH, Chang NC . Risk estimates for drugs suspected of being associated with Stevens-Johnson syndrome and toxic epidermal necrolysis: a case-control study. Intern Med J 2005; 35: 188\u2013190.","journal-title":"Intern Med J"},{"key":"BFtpj201084_CR5","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1038\/sj.jid.5701033","volume":"128","author":"M Mockenhaupt","year":"2008","unstructured":"Mockenhaupt M, Viboud C, Dunant A, Naldi L, Halevy S, Bouwes Bavinck JN et al. Stevens-Johnson syndrome and toxic epidermal necrolysis: assessment of medication risks with emphasis on recently marketed drugs. The EuroSCAR-study. J Invest Dermatol 2008; 128: 35\u201344.","journal-title":"J Invest Dermatol"},{"key":"BFtpj201084_CR6","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1038\/428486a","volume":"428","author":"W-H Chung","year":"2004","unstructured":"Chung W-H, Hung S-I, Hong H-S, Hsih M-S, Yang L-C, Ho H-C et al. Medical genetics: a marker for Stevens-Johnson syndrome. Nature 2004; 428: 486.","journal-title":"Nature"},{"key":"BFtpj201084_CR7","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1038\/sj.tpj.6500356","volume":"6","author":"C Lonjou","year":"2006","unstructured":"Lonjou C, Thomas L, Borot N, Ledger N, de Toma C, LeLouet H et al. A marker for Stevens-Johnson syndrome: ethnicity matters. Pharmacogenomics J 2006; 6: 265\u2013268.","journal-title":"Pharmacogenomics J"},{"key":"BFtpj201084_CR8","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1097\/01.fpc.0000199500.46842.4a","volume":"16","author":"SI Hung","year":"2006","unstructured":"Hung SI, Chung WH, Jee SH, Chen WC, Chang YT, Lee WR et al. Genetic susceptibility to carbamazepine-induced cutaneous adverse drug reactions. Pharmacogenet Genomics 2006; 16: 297\u2013306.","journal-title":"Pharmacogenet Genomics"},{"key":"BFtpj201084_CR9","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1111\/j.1528-1167.2007.01022.x","volume":"48","author":"CB Man","year":"2007","unstructured":"Man CB, Kwan P, Baum L, Yu E, Lau KM, Cheng AS et al. Association between HLA-B*1502 allele and antiepileptic drug-induced cutaneous reactions in Han Chinese. Epilepsia 2007; 48: 1015\u20131018.","journal-title":"Epilepsia"},{"key":"BFtpj201084_CR10","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1001\/archderm.1987.01660330082014","volume":"123","author":"JC Roujeau","year":"1987","unstructured":"Roujeau JC, Huynh TN, Bracq C, Guillaume JC, Revuz J, Touraine R . Genetic susceptibility to toxic epidermal necrolysis. Arch Dermatol 1987; 123: 1171\u20131173.","journal-title":"Arch Dermatol"},{"key":"BFtpj201084_CR11","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.jaad.2007.08.036","volume":"58","author":"S Halevy","year":"2008","unstructured":"Halevy S, Ghislain PD, Mockenhaupt M, Fagot JP, Bouwes Bavinck JN, Sidoroff A et al. Allopurinol is the most common cause of Stevens-Johnson syndrome and toxic epidermal necrolysis in Europe and Israel. J Am Acad Dermatol 2008; 58: 25\u201332.","journal-title":"J Am Acad Dermatol"},{"key":"BFtpj201084_CR12","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1097\/FPC.0b013e3282f3ef9c","volume":"18","author":"C Lonjou","year":"2008","unstructured":"Lonjou C, Borot N, Sekula P, Ledger N, Thomas L, Halevy S et al. A European study of HLA-B in Stevens-Johnson syndrome and toxic epidermal necrolysis related to five high-risk drugs. Pharmacogenet Genomics 2008; 18: 99\u2013107.","journal-title":"Pharmacogenet Genomics"},{"key":"BFtpj201084_CR13","doi-asserted-by":"publisher","first-page":"4134","DOI":"10.1073\/pnas.0409500102","volume":"102","author":"SI Hung","year":"2005","unstructured":"Hung SI, Chung WH, Liou LB, Chu CC, Lin M, Huang HP et al. HLA-B*5801 allele as a genetic marker for severe cutaneous adverse reactions caused by allopurinol. Proc Natl Acad Sci USA 2005; 102: 4134\u20134139. Epub 2005 Mar 4132.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFtpj201084_CR14","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.ajo.2006.09.029","volume":"143","author":"M Ueta","year":"2007","unstructured":"Ueta M, Sotozono C, Tokunaga K, Yabe T, Kinoshita S . Strong association between HLA-A*0206 and Stevens-Johnson syndrome in the Japanese. Am J Ophthalmol 2007; 143: 367\u2013368.","journal-title":"Am J Ophthalmol"},{"key":"BFtpj201084_CR15","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.2217\/14622416.8.12.1661","volume":"8","author":"M Pirmohamed","year":"2007","unstructured":"Pirmohamed M, Arbuckle JB, Bowman CE, Brunner M, Burns DK, Delrieu O et al. Investigation into the multidimensional genetic basis of drug-induced Stevens-Johnson syndrome and toxic epidermal necrolysis. Pharmacogenomics 2007; 8: 1661\u20131691.","journal-title":"Pharmacogenomics"},{"key":"BFtpj201084_CR16","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1097\/FPC.0b013e32832c347d","volume":"19","author":"GR Kazeem","year":"2009","unstructured":"Kazeem GR, Cox C, Aponte J, Messenheimer J, Brazell C, Nelsen AC et al. High-resolution HLA genotyping and severe cutaneous adverse reactions in lamotrigine-treated patients. Pharmacogenet Genomics 2009; 19: 661\u2013665.","journal-title":"Pharmacogenet Genomics"},{"key":"BFtpj201084_CR17","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1038\/nature09298","volume":"467","author":"The International HapMap 3 Consortium","year":"2010","unstructured":"The International HapMap 3 Consortium. Integrating common and rare genetic variation in diverse human populations. Nature 2010; 467: 52\u201358.","journal-title":"Nature"},{"key":"BFtpj201084_CR18","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1038\/ng.379","volume":"41","author":"AK Daly","year":"2009","unstructured":"Daly AK, Donaldson PT, Bhatnagar P, Shen Y, Pe\u2032er I, Floratos A et al. HLA-B*5701 genotype is a major determinant of drug-induced liver injury due to flucloxacillin. Nat Genet 2009; 41: 816\u2013819.","journal-title":"Nat Genet"},{"key":"BFtpj201084_CR19","unstructured":"Purcell S . PLINK v 1.05."},{"key":"BFtpj201084_CR20","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1086\/519795","volume":"81","author":"S Purcell","year":"2007","unstructured":"Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MAR, Bender D et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 2007; 81: 559\u2013575.","journal-title":"Am J Hum Genet"},{"key":"BFtpj201084_CR21","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1038\/ng1847","volume":"38","author":"AL Price","year":"2006","unstructured":"Price AL, Patterson NJ, Plenge RM, Weinblatt ME, Shadick NA, Reich D . Principal components analysis corrects for stratification in genome-wide association studies. Nat Genet 2006; 38: 904\u2013909.","journal-title":"Nat Genet"},{"key":"BFtpj201084_CR22","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1038\/nature07331","volume":"456","author":"J Novembre","year":"2008","unstructured":"Novembre J, Johnson T, Bryc K, Kutalik Z, Boyko AR, Auton A et al. Genes mirror geography within Europe. Nature 2008; 456: 98\u2013101.","journal-title":"Nature"},{"key":"BFtpj201084_CR23","unstructured":"R Development Core Team. R. A Language and Environment for Statistical Computing, vol. 1. Vienna Austria R Foundation for Statistical Computing, 2009. Available from http:\/\/www.r-project.org."},{"key":"BFtpj201084_CR24","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.1101\/gr.6861907","volume":"17","author":"K Wang","year":"2007","unstructured":"Wang K, Li M, Hadley D, Liu R, Glessner J, Grant SF et al. PennCNV: an integrated hidden Markov model designed for high-resolution copy number variation detection in whole-genome SNP genotyping data. Genome Res 2007; 17: 1665\u20131674.","journal-title":"Genome Res"},{"key":"BFtpj201084_CR25","doi-asserted-by":"publisher","first-page":"e1000373","DOI":"10.1371\/journal.pgen.1000373","volume":"5","author":"AC Need","year":"2009","unstructured":"Need AC, Ge D, Weale ME, Maia J, Feng S, Heinzen EL et al. A genome-wide investigation of SNPs and CNVs in schizophrenia. PLoS Genet 2009; 5: e1000373.","journal-title":"PLoS Genet"},{"key":"BFtpj201084_CR26","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1126\/science.1155174","volume":"320","author":"T Walsh","year":"2008","unstructured":"Walsh T, McClellan JM, McCarthy SE, Addington AM, Pierce SB, Cooper GM et al. Rare structural variants disrupt multiple genes in neurodevelopmental pathways in schizophrenia. Science 2008; 320: 539\u2013543.","journal-title":"Science"},{"key":"BFtpj201084_CR27","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.ajhg.2008.08.005","volume":"83","author":"MR Nelson","year":"2008","unstructured":"Nelson MR, Bryc K, King KS, Indap A, Boyko AR, Novembre J et al. The population reference sample, POPRES: a resource for population, disease, and pharmacological genetics research. Am J Hum Genet 2008; 83: 347\u2013358.","journal-title":"Am J Hum Genet"},{"key":"BFtpj201084_CR28","unstructured":"Wellcome trust case control consortium\u2014phase 2, downloaded from http:\/\/www.ebi.ac.uk\/ega\/page.php."},{"key":"BFtpj201084_CR29","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1038\/tpj.2008.4","volume":"9","author":"MR Nelson","year":"2009","unstructured":"Nelson MR, Bacanu SA, Mosteller M, Li L, Bowman CE, Roses AD et al. Genome-wide approaches to identify pharmacogenetic contributions to adverse drug reactions. Pharmacogenomics J 2009; 9: 23\u201333.","journal-title":"Pharmacogenomics J"},{"key":"BFtpj201084_CR30","doi-asserted-by":"publisher","first-page":"1792","DOI":"10.1126\/science.1129947","volume":"313","author":"Y Fukata","year":"2006","unstructured":"Fukata Y, Adesnik H, Iwanaga T, Bredt DS, Nicoll RA, Fukata M . Epilepsy-related ligand\/receptor complex LGI1 and ADAM22 regulate synaptic transmission. Science 2006; 313: 1792\u20131795.","journal-title":"Science"},{"key":"BFtpj201084_CR31","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/j.ygeno.2007.03.017","volume":"90","author":"JA Jacobsson","year":"2007","unstructured":"Jacobsson JA, Haitina T, Lindblom J, Fredriksson R . Identification of six putative human transporters with structural similarity to the drug transporter SLC22 family. Genomics 2007; 90: 595\u2013609.","journal-title":"Genomics"},{"key":"BFtpj201084_CR32","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1007\/s11095-006-9181-4","volume":"24","author":"A Rizwan","year":"2007","unstructured":"Rizwan A, Burckhardt G . Organic anion transporters of the SLC22 family: biopharmaceutical, physiological, and pathological roles. Pharm Res 2007; 24: 450\u2013470.","journal-title":"Pharm Res"},{"key":"BFtpj201084_CR33","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1097\/00062752-200301000-00003","volume":"10","author":"MC Dinauer","year":"2003","unstructured":"Dinauer MC . Regulation of neutrophil function by Rac GTPases. Curr Opin Hematol 2003; 10: 8\u201315.","journal-title":"Curr Opin Hematol"},{"key":"BFtpj201084_CR34","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1189\/jlb.0406251","volume":"81","author":"T Zhao","year":"2007","unstructured":"Zhao T, Nalbant P, Hoshino M, Dong X, Wu D, Bokoch GM . Signaling requirements for translocation of P-Rex1, a key Rac2 exchange factor involved in chemoattractant-stimulated human neutrophil function. J Leukoc Biol 2007; 81: 1127\u20131136.","journal-title":"J Leukoc Biol"},{"key":"BFtpj201084_CR35","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.cellimm.2008.08.007","volume":"254","author":"E Aktas","year":"2009","unstructured":"Aktas E, Kucuksezer UC, Bilgic S, Erten G, Deniz G . Relationship between CD107a expression and cytotoxic activity. Cell Immunol 2009; 254: 149\u2013154.","journal-title":"Cell Immunol"},{"key":"BFtpj201084_CR36","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1002\/cyto.a.20068","volume":"61","author":"A Grutzkau","year":"2004","unstructured":"Grutzkau A, Smorodchenko A, Lippert U, Kirchhof L, Artuc M, Henz BM . LAMP-1 and LAMP-2, but not LAMP-3, are reliable markers for activation-induced secretion of human mast cells. Cytometry A 2004; 61: 62\u201368.","journal-title":"Cytometry A"},{"key":"BFtpj201084_CR37","doi-asserted-by":"publisher","first-page":"4219","DOI":"10.1242\/jcs.01288","volume":"117","author":"A Dani","year":"2004","unstructured":"Dani A, Chaudhry A, Mukherjee P, Rajagopal D, Bhatia S, George A et al. The pathway for MHCII-mediated presentation of endogenous proteins involves peptide transport to the endo-lysosomal compartment. J Cell Sci 2004; 117: 4219\u20134230.","journal-title":"J Cell Sci"},{"key":"BFtpj201084_CR38","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1126\/science.1108003","volume":"307","author":"L Delamarre","year":"2005","unstructured":"Delamarre L, Pack M, Chang H, Mellman I, Trombetta ES . Differential lysosomal proteolysis in antigen-presenting cells determines antigen fate. Science 2005; 307: 1630\u20131634.","journal-title":"Science"},{"key":"BFtpj201084_CR39","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1038\/nature07517","volume":"456","author":"DR Bentley","year":"2008","unstructured":"Bentley DR, Balasubramanian S, Swerdlow HP, Smith GP, Milton J, Brown CG et al. Accurate whole human genome sequencing using reversible terminator chemistry. Nature 2008; 456: 53\u201359.","journal-title":"Nature"},{"key":"BFtpj201084_CR40","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1038\/nature03959","volume":"437","author":"M Margulies","year":"2005","unstructured":"Margulies M, Egholm M, Altman WE, Attiya S, Bader JS, Bemben LA et al. Genome sequencing in microfabricated high-density picolitre reactors. Nature 2005; 437: 376\u2013380.","journal-title":"Nature"},{"key":"BFtpj201084_CR41","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1038\/nature07484","volume":"456","author":"J Wang","year":"2008","unstructured":"Wang J, Wang W, Li R, Li Y, Tian G, Goodman L et al. The diploid genome sequence of an Asian individual. Nature 2008; 456: 60\u201365.","journal-title":"Nature"},{"key":"BFtpj201084_CR42","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1038\/nature08250","volume":"461","author":"SB Ng","year":"2009","unstructured":"Ng SB, Turner EH, Robertson PD, Flygare SD, Bigham AW, Lee C et al. Targeted capture and massively parallel sequencing of 12 human exomes. Nature 2009; 461: 272\u2013276.","journal-title":"Nature"},{"key":"BFtpj201084_CR43","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1038\/ng.499","volume":"42","author":"SB Ng","year":"2010","unstructured":"Ng SB, Buckingham KJ, Lee C, Bigham AW, Tabor HK, Dent KM et al. Exome sequencing identifies the cause of a mendelian disorder. Nat Genet 2010; 42: 30\u201335.","journal-title":"Nat Genet"},{"key":"BFtpj201084_CR44","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1056\/NEJMoa0908094","volume":"362","author":"JR Lupski","year":"2010","unstructured":"Lupski JR, Reid JG, Gonzaga-Jauregui C, Rio Deiros D, Chen DCY, Nazareth L et al. Whole-genome sequencing in a patient with Charcot-Marie-Tooth neuropathy. N Engl J Med 2010; 362: 1181\u20131191.","journal-title":"N Engl J Med"},{"key":"BFtpj201084_CR45","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1126\/science.1186802","volume":"328","author":"JC Roach","year":"2010","unstructured":"Roach JC, Glusman G, Smit AF, Huff CD, Hubley R, Shannon PT et al. Analysis of genetic inheritance in a family quartet by whole-genome sequencing. Science 2010; 328: 636\u2013639.","journal-title":"Science"}],"container-title":["The Pharmacogenomics Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/tpj201084.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/tpj201084","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/tpj201084.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,22]],"date-time":"2022-03-22T10:29:58Z","timestamp":1647944998000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/tpj201084"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,1,11]]},"references-count":45,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,4]]}},"alternative-id":["BFtpj201084"],"URL":"https:\/\/doi.org\/10.1038\/tpj.2010.84","relation":{},"ISSN":["1470-269X","1473-1150"],"issn-type":[{"value":"1470-269X","type":"print"},{"value":"1473-1150","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,1,11]]},"assertion":[{"value":"14 January 2010","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 October 2010","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 October 2010","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 January 2011","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The author declares no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}